Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects
Dario Cattaneo(ASST Fatebenefratelli Sacco), Emilio Clementi(Luigi Sacco Hospital), Simona Landonio(ASST Fatebenefratelli Sacco), Sara Baldelli(Luigi Sacco Hospital), Marco Pellegrini(University of Ferrara), Valeria Cozzi(Luigi Sacco Hospital), Serena Fucile(Luigi Sacco Hospital), Paola Meraviglia(Luigi Sacco Hospital), Cristina Gervasoni(University of Padua), Massimo Galli(Luigi Sacco Hospital)
Cited by 58
Related Papers
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|589
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals
|Proceedings of the National Academy of Sciences|2004|496
Autophagy as a new therapeutic target in Duchenne muscular dystrophy
|Cell Death and Disease|2012|265
Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV
|HIV Medicine|2020|166